Structured evidence table for Glucosamine Joint Stiffness Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Glucosamine Joint Stiffness Randomized Trial | It causes chronic pain, reduced mobility, and disability, affecting 607 million individuals worldwide, with nearly 46.6 million new cases annually []. | 4 | Muacevic Alexander (2026) | Evidence-Based Use of Undenatured Type II Collagen in the Management of Osteoarthritis in the Indian Subcontinent and Southeast Asia: A Narrative Review and an Expert Opinion |
| Glucosamine Joint Stiffness Randomized Trial | 11 12 13 14 15 11 15 HLA-DRB1 HLA-DQB1 Genetic polymorphisms in sterol regulatory element-binding protein 2 (rs2228314) [], interleukin-6 (rs1800795) [], and resistin (RETN) [] in Indian and Pakistani cohorts and growth differentiation factor 5 (rs143383) [],, andin Thai populations [] are linked to OA risk. | 4 | Muacevic Alexander (2026) | Evidence-Based Use of Undenatured Type II Collagen in the Management of Osteoarthritis in the Indian Subcontinent and Southeast Asia: A Narrative Review and an Expert Opinion |
| Glucosamine Joint Stiffness Randomized Trial | Need for expert opinion Despite growing clinical and mechanistic evidence for collagen supplementation in OA, several gaps and challenges remain in translating this knowledge into clinical practice, especially in the Indian subcontinent and Southeast Asia. | 4 | Muacevic Alexander (2026) | Evidence-Based Use of Undenatured Type II Collagen in the Management of Osteoarthritis in the Indian Subcontinent and Southeast Asia: A Narrative Review and an Expert Opinion |
| Glucosamine Joint Stiffness Randomized Trial | 1 2 3 4 6 7 8 9 10 1 Osteoarthritis (OA) is the most prevalent degenerative joint disease globally and the second most common rheumatologic condition []. | 4 | Muacevic Alexander (2026) | Evidence-Based Use of Undenatured Type II Collagen in the Management of Osteoarthritis in the Indian Subcontinent and Southeast Asia: A Narrative Review and an Expert Opinion |
| Glucosamine Joint Stiffness Randomized Trial | longa extract produced a significant reduction in pain and clinical signs associated with OA. | 4 | Tripathi SD (2026) | Protective effects of turmerosaccharides rich extract of <i>Curcuma longa</i> L. in osteoarthritic dogs. |
| Glucosamine Joint Stiffness Randomized Trial | Introduction Osteoarthritis (OA) is a progressive degenerative joint disease characterized by cartilage deterioration, leading to chronic pain and impaired immobility particularly in older dogs. | 4 | Tripathi SD (2026) | Protective effects of turmerosaccharides rich extract of <i>Curcuma longa</i> L. in osteoarthritic dogs. |
| Glucosamine Joint Stiffness Randomized Trial | Aim This study investigated the protective effects of a turmerosaccharides-rich extract of Curcuma longa L. | 4 | Tripathi SD (2026) | Protective effects of turmerosaccharides rich extract of <i>Curcuma longa</i> L. in osteoarthritic dogs. |
Source documents